 | This article needs additional citations for verification. (December 2011) |
 | |
| Company type | Public |
|---|---|
| BSE: 532649 NSE: NECLIFE | |
| Industry | Pharmaceuticals |
| Founded | 1995 |
| Headquarters | Chandigarh, India |
Key people |
|
| Products | Pharmaceuticals, |
| Revenue |  ₹ 31.14 billion |
| ₹ 1.05 billion | |
Number of employees | 2200 |
| Website | www |
Nectar Lifesciences Limited is a pharmaceutical company in India that manufactures generic drug products.[1] The company has global leadership in several oral and sterile cephalosporin drugs, and has cGMP facilities along with those approved by the European Union and Japan.[2]
- ^ "NECTAR LIFESCIENCES LTD (NECLIFE:National Stock Exchange of India): Stock Quote & Company Profile - Businessweek". investing.businessweek.com. Archived from the original on 18 January 2013. Retrieved 28 September 2012.
- ^ "Nectar Lifesciences Limited (Neclife) Receives Anvisa Approval For Its Cephalosporin API's Manufacturing Facility". Institute of Good Manufacturing Practices India. Retrieved 1 July 2018.